Class / Patent application number | Description | Number of patent applications / Date published |
548509000 | Chalcogen attached indirectly to the bicyclo ring system by acyclic nonionic bonding | 6 |
20110004005 | RHODIUM-PHOSPHORUS COMPLEXES AND THEIR USE IN RING OPENING REACTIONS - The present invention is directed to novel rhodium-phosphorus complexes of formula: [Rh(PP′)(solv) | 01-06-2011 |
20160083409 | METHOD FOR THE PREPARATION OF alpha-SUBSTITUTED ACRYL ALDEHYDES - The invention discloses simple and rapid method for the preparation of α-substituted acryl aldehydes. More particularly, the invention discloses a method for the preparation of α-substituted acryl aldehydes via a gold-catalysed [1,3] rearrangement of the allenyl ethers with a record turnover frequency of 4600 h | 03-24-2016 |
548510000 | The chalcogen, X, is in a -C(=X)- group | 4 |
20080221337 | Process for Producing an Aromatic Unsaturated Compound - The present invention provides a process for producing an aromatic unsaturated compound of the formula (4) | 09-11-2008 |
20090036690 | ORGANIC COMPOUNDS - The use of indole carbamates as fragrance ingredients and fragrance applications comprising indole carbamates in an effective amount. | 02-05-2009 |
20090192319 | METHODS FOR TREATING COGNITIVE /ATTENTION DEFICIT DISORDERS USING TETRAHYDROINDOLONE ANALOGUES AND DERIVATIVES - Methods for treating cognitive/attention deficit disorders in general using tetrahydroindolone derivatives and analogues, particularly tetrahydroindolone derivatives or analogues in which the tetrahydroindolone derivative or analogue is covalently linked to another moiety to form a bifunctional conjugate are disclosed. More specifically, methods and compositions for treating attention deficit disorder and attention deficit hyperactivity disorders in adults and children as well as mild cognitive impairment and dementia are provided. The compounds used to treat and/or palliate cognitive/attention deficit disorders in general include a tetrahydroindolone derivative or analogue comprises a 9-atom bicyclic moiety, moiety A, linked through a linker L to a moiety B, where B is a carboxylic acid, a carboxylic acid ester, or a moiety of the structure N(Y | 07-30-2009 |
20150148548 | Silodosin Intermediate and Preparation Method Therefor - Disclosed are a silodosin intermediate and a preparation method thereof. The silodosin intermediate has the structure shown by the formula (A). X is hydrogen or bromide and R | 05-28-2015 |